Arax Advisory Partners’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.33K Buy
+317
New +$4.45K ﹤0.01% 4574
2025
Q4
Sell
-83
Closed -$1.8K 4481
2025
Q3
$1.8K Buy
+83
New +$1.85K ﹤0.01% 3137
2025
Q1
Sell
-31
Closed -$657 3006
2024
Q4
$657 Buy
+31
New +$813 ﹤0.01% 2270
2023
Q4
Sell
-300
Closed -$8.78K 1415
2023
Q3
$8.78K Buy
+300
New +$10.8K ﹤0.01% 750

Other funds holding SGRY

Arax Advisory Partners's SGRY Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Surgery Partners (SGRY) in Q2 2026: 317 shares worth $5.33K. The stake represents ﹤0.01% of the portfolio and ranks #4574 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in SGRY as recently as Q3 2025.

Arax Advisory Partners first reported a position in SGRY in Q3 2023 and has held it in 4 quarters since. The position peaked at $8.78K in Q3 2023. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Arax Advisory Partners held 317 shares of Surgery Partners worth $5.33K as of Q2 2026.
  • Surgery Partners was a new Arax Advisory Partners position in Q2 2026.
  • Surgery Partners made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4574 holding.
  • Arax Advisory Partners first reported a position in Surgery Partners in Q3 2023 and has held it in 4 quarters since.
  • Arax Advisory Partners's Surgery Partners position peaked at $8.78K in Q3 2023.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.